Clinical evidence regarding factors linking metabolic abnormal obesity to pancreatic β‐cell dysfunction
Main Author: | Hirotaka Watada |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-07-01
|
Series: | Journal of Diabetes Investigation |
Online Access: | https://doi.org/10.1111/jdi.13264 |
Similar Items
-
Inceptor intercepts insulin signaling in pancreatic β‐cells
by: Hirotaka Watada
Published: (2021-09-01) -
Unappreciated role of low‐density lipoprotein receptor‐related protein 1 in pancreatic β cells: Multiple roles of low‐density lipoprotein receptor‐related protein 1 in glucose and lipid metabolism
by: Hirotaka Watada
Published: (2019-03-01) -
Mechanisms of Insulin Resistance at the Crossroad of Obesity with Associated Metabolic Abnormalities and Cognitive Dysfunction
by: Thomas M. Barber, et al.
Published: (2021-01-01) -
Diminished Sphingolipid Metabolism, a Hallmark of Future Type 2 Diabetes Pathogenesis, Is Linked to Pancreatic β Cell Dysfunction
by: Saifur R. Khan, et al.
Published: (2020-10-01) -
Hyperglycaemia induces metabolic dysfunction and glycogen accumulation in pancreatic β-cells
by: Melissa F. Brereton, et al.
Published: (2016-11-01)